Abstract
Diabetes mellitus (DM) is one of the most common chronic diseases worldwide and its prevalence is expected to increase in the coming years. Therefore, updated knowledge of all diabetic complications and their management is essential for the proper treatment of these patients. Sexual dysfunctions are one of the long-term complications of DM in both genders. However, female sexuality is still a taboo and sexual concerns are often overlooked, underdiagnosed, and untreated. The aim of this review is to summarize the current knowledge on the relationship between sexual function and DM in women. In particular, we evaluated the prevalence, etiology, diagnostic approaches, and current treatment options of female sexual dysfunction (FSD) in diabetic patients.
Highlights
Diabetes mellitus (DM) is one of the most common chronic diseases worldwide
Regarding the relationship between the type of the therapeutic strategy for DM and sexuality, previous studies have shown a higher prevalence of female sexual dysfunction (FSD) in women with multiple-dose injection compared to continuous subcutaneous insulin infusion [17,30]
DM is one of the most common chronic diseases worldwide and its prevalence is expected to increase in the coming years
Summary
Diabetes mellitus (DM) is one of the most common chronic diseases worldwide. The global diabetes prevalence in 2019 has been estimated to be 9.3% (463 million people) and this number is expected to increase by 25% in 2030 and by 51% in 2045 [1]. DM is associated with many long-term systemic complications among which sexual dysfunction is one of them in both genders. In recent years, this aspect has been more extensively studied in men than in women. Sexual dysfunctions in diabetic women are often overlooked due to social taboos on female sexuality [2]. The analysis of the National Health and Social Life Survey showed that sexual dysfunctions are more frequent in women (43%) than in men (31%) in the US population [3]. The attention on female sexual dysfunction (FSD) has been growing. We evaluated the prevalence, etiology, diagnostic approaches, and treatment options of FSD in diabetic women
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
